NASDAQ NMS - GLOBAL MARKET · GDRX
-0.84% · -$0.0250 · Vol 274.2K
Live · updated 14:14:09 ET
GoodRx Holdings Inc

GoodRx Holdings Inc

Health Care
$2.94

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is GDRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About GoodRx Holdings Inc
SERVICES-COMPUTER PROCESSING & DATA PREPARATION
Listed since
2020
Employees
697
Country
US

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.97
Day high
$2.98
Day low
$2.91
Previous close
$2.96
52W high
$3.06
-4.24% from high
52W low
$2.54
75% of range
Market cap
$1B
P/E
41.93×
EPS
$0.0700
Shares out
338.7M
Volume
274.2K
VWAP
$2.95
Price history computed in-house
1W
-3.14%
1M
+14.65%
SMA 50 $2.79 · above
SMA 200 $2.79 · above
52W position 75%
Veridion warehouse edge

Warehouse intelligence for GDRX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

GDRX insider activity

GoodRx Holdings Inc

Score
Coverage building
Pressure
Net selling
Filings
30
Buys / sells
1 / 29
Net value
-$1.3M
Insiders
6
Named filers
CT
Chan Thomas (TC)
Insider
Leadership
MA
McGinnis Christopher A
Insider
Leadership
BL
Barnes Wendy Lynn
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$1.3M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-152026-06-15Chan Thomas (TC)Insidersell$2.651,0695,735$3KSEC Form 4
2026-06-152026-06-15Chan Thomas (TC)Insidersell$2.651,0024,704$3KSEC Form 4
2026-05-152026-05-15Chan Thomas (TC)Insidersell$2.498583,737$2KSEC Form 4
2026-05-152026-05-15Chan Thomas (TC)Insidersell$2.491,3422,909$3KSEC Form 4
2026-05-152026-05-15Chan Thomas (TC)Insidersell$2.496381,614$2KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 25 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GDRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GDRX in this window.
Lobbying spend

GDRX lobbying filings, year to date.

Registered lobbying filings matched to GoodRx Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GDRX in this window.
Latest news · GDRX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GDRX.
Options
Sovereign unlock shows live options positioning for GDRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.